Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 8 | 2009 | 109 | 1.860 |
Why?
|
| Kidney Neoplasms | 8 | 2009 | 192 | 1.740 |
Why?
|
| Catheter Ablation | 4 | 2009 | 62 | 0.820 |
Why?
|
| Cryosurgery | 3 | 2009 | 19 | 0.500 |
Why?
|
| Wounds, Gunshot | 2 | 2008 | 34 | 0.380 |
Why?
|
| Population Surveillance | 2 | 2009 | 119 | 0.360 |
Why?
|
| Cryotherapy | 1 | 2009 | 13 | 0.350 |
Why?
|
| Suburethral Slings | 1 | 2009 | 11 | 0.350 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2009 | 17 | 0.350 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 45 | 0.340 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2008 | 7 | 0.320 |
Why?
|
| Penis | 1 | 2008 | 33 | 0.320 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2008 | 337 | 0.310 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2007 | 20 | 0.300 |
Why?
|
| Urethra | 1 | 2008 | 100 | 0.300 |
Why?
|
| Ureter | 1 | 2006 | 35 | 0.290 |
Why?
|
| Nephrectomy | 4 | 2008 | 114 | 0.280 |
Why?
|
| Lipoma | 1 | 2005 | 8 | 0.270 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2005 | 179 | 0.220 |
Why?
|
| Radiography | 3 | 2009 | 353 | 0.220 |
Why?
|
| Disease Progression | 3 | 2008 | 572 | 0.200 |
Why?
|
| Retrospective Studies | 5 | 2009 | 3121 | 0.190 |
Why?
|
| Humans | 14 | 2009 | 29213 | 0.190 |
Why?
|
| Prognosis | 4 | 2008 | 1363 | 0.180 |
Why?
|
| NF-kappa B | 2 | 2008 | 75 | 0.160 |
Why?
|
| Male | 9 | 2009 | 17872 | 0.150 |
Why?
|
| Neoplasm Staging | 3 | 2008 | 437 | 0.150 |
Why?
|
| Middle Aged | 6 | 2008 | 10868 | 0.150 |
Why?
|
| Adolescent | 3 | 2009 | 3265 | 0.140 |
Why?
|
| Prostatic Neoplasms | 2 | 2008 | 441 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2008 | 1312 | 0.120 |
Why?
|
| Cation Transport Proteins | 2 | 2008 | 24 | 0.100 |
Why?
|
| Adult | 4 | 2008 | 8466 | 0.100 |
Why?
|
| Registries | 2 | 2008 | 280 | 0.090 |
Why?
|
| Polypropylenes | 1 | 2009 | 7 | 0.090 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2009 | 15 | 0.090 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2009 | 27 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2008 | 440 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2008 | 23 | 0.080 |
Why?
|
| Philadelphia | 1 | 2008 | 5 | 0.080 |
Why?
|
| Zinc | 1 | 2008 | 32 | 0.080 |
Why?
|
| Scrotum | 1 | 2008 | 8 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2008 | 10 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 39 | 0.080 |
Why?
|
| Incidence | 2 | 2008 | 1123 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 103 | 0.080 |
Why?
|
| Cause of Death | 1 | 2008 | 220 | 0.080 |
Why?
|
| Multiple Trauma | 1 | 2008 | 38 | 0.080 |
Why?
|
| Injury Severity Score | 1 | 2008 | 116 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2008 | 225 | 0.080 |
Why?
|
| Trauma Centers | 1 | 2008 | 88 | 0.080 |
Why?
|
| Age Distribution | 1 | 2008 | 198 | 0.080 |
Why?
|
| Urinoma | 1 | 2006 | 1 | 0.070 |
Why?
|
| Nomograms | 1 | 2007 | 30 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2007 | 68 | 0.070 |
Why?
|
| Female | 4 | 2008 | 18236 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2007 | 163 | 0.070 |
Why?
|
| Aged | 3 | 2008 | 9510 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2007 | 448 | 0.070 |
Why?
|
| Urination Disorders | 1 | 2005 | 5 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 301 | 0.070 |
Why?
|
| Length of Stay | 1 | 2006 | 294 | 0.070 |
Why?
|
| Kidney | 1 | 2009 | 486 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 525 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 788 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 466 | 0.060 |
Why?
|
| Algorithms | 1 | 2007 | 463 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2008 | 670 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2007 | 1694 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2114 | 0.050 |
Why?
|
| Young Adult | 1 | 2009 | 2413 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2007 | 2027 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 871 | 0.050 |
Why?
|
| Time Factors | 1 | 2006 | 2003 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2008 | 3108 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 3726 | 0.040 |
Why?
|
| Transfection | 2 | 2008 | 192 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 681 | 0.040 |
Why?
|
| SEER Program | 1 | 2008 | 33 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2008 | 60 | 0.020 |
Why?
|
| Ethylenediamines | 1 | 2008 | 6 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 31 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2008 | 17 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 150 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 89 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 76 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 36 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 189 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 519 | 0.020 |
Why?
|
| Age Factors | 1 | 2008 | 1110 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 666 | 0.020 |
Why?
|
| Mice | 1 | 2008 | 2372 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 7302 | 0.010 |
Why?
|